MedPath

Asthma Control Study

Not Applicable
Completed
Conditions
Childhood Asthma
Interventions
Behavioral: Tueo Program
Registration Number
NCT03304067
Lead Sponsor
Evidation Health
Brief Summary

The "Digital Health Tool for Parental Management of Childhood Asthma -- Impact on Asthma Control Test Scores" Study is a 16 week, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Tueo Health program on asthma control as indicated by change in baseline and study end (week 16) score on the Childhood Asthma Control Test score (ages 6- under 12 years) and the Asthma Control Test (ages 12-17 years) in children with uncontrolled asthma as the primary study objective.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
262
Inclusion Criteria
  • Parent has a child who is > 6 and < 17.5 years old
  • Parent reports child has a diagnosis of asthma
  • Child takes daily asthma controller medication
  • Child has used rescue inhaler (e.g.albuterol, ProAir, etc) or nebulizer at least 2 times per week in the past 4 weeks
  • Child sleeps on a toddler, single, or double bed by themselves
  • Child will live in the same home for the majority of the next 16 weeks
  • Parent is > 18 years old
Exclusion Criteria
  • Child's asthma has been controlled over the past 4 weeks
  • Child has any of the following conditions: sleep apnea, congenital heart disease, cardiac arrhythmias, or any other heart abnormalities, neurologic conditions including seizures, cerebral palsy, muscular dystrophy, genetic conditions or developmental disorders, autism, other major medical condition
  • Child is currently pregnant
  • Child was born premature (earlier than 36 weeks)
  • Parent is not fluent in English
  • No in-home WiFi
  • Parent does not use an Android phone as their primary phone
  • In a household with an existing enrolled participant in the study, even for a different child (e.g. only one child in a household may have questions reported back to the researchers by their parent)
  • Lives in Hawaii or Alaska

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionTueo Program-
Primary Outcome Measures
NameTimeMethod
Change in ACT/C-ACT scoresBaseline and Week 16

Change in ACT/C-ACT scores from baseline to study end

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Evidation Health

🇺🇸

San Mateo, California, United States

© Copyright 2025. All Rights Reserved by MedPath